HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Bismuth Subnitrate

HCID 73415757
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1304-85-4
Standard SMILES
O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-2].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-]
InChIKey
QGWDKKHSDXWPET-UHFFFAOYSA-E
Molecular formula
Bi5H9N4O22
Average molar mass
1,461.99 g/mol
Monoisotopic mass
1,461.87284

Overview

Bismuth subnitrate, also referred to as bismuth oxynitrate or bismuthyl nitrate, is a highly water-soluble crystalline compound that has been used as a treatment for duodenal ulcers and anti-diarrheic agent. The use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA.

Names & identifiers

Preferred name
Bismuth Subnitrate
IUPAC
pentabismuth;oxygen(2-);nonahydroxide;tetranitrate
English name
Bismuth subnitrate
Molecular formula
Bi5H9N4O22
Molecular weight
1461.99

Names & synonyms

Bismuth nitrate, basicBasic bismuth nitrateNovismuthVicalinVikalineBismuth paintBismuth SynlabBismuth WhiteCosmetic WhiteSpanish WhiteFlake WhitePaint White
Show more names
BISMUTH OXYNITRATEc.i.77169flakewhitepaintwhitesnowcal5swblancdefardbismuthpaint
Blanc de fardBismuth magisteryBismuthyl nitrateBismuth subnitricumSnowcal 5SWSnowcal 5 SWBismuthum subnitricumMagistery of bismuth

Database identifiers

CAS
1304-85-4、54392-33-5
PubChem CID
73415757
DTXSID
DTXSID40893872
ChEMBL
CHEMBL3833348
UNII
H19J064BA5
EC Number
215-136-8、611-133-4

Properties

Computed structural properties

Topological polar surface area
262 Ų
Hydrogen bond donors
9
Hydrogen bond acceptors
22
Rotatable bonds
0
Heavy atoms
31
Formal charge
0
Complexity
18.8

Experimental & physicochemical properties

Chemical ClassesMetals -> Metals, Inorganic Compounds
CosmeticsOpacifying; Absorbent
pHSHOWS ACID TO MOISTENED LITMUS PAPER
OdorODORLESS
TasteTASTELESS
Density4.928
Color/Form · 2 items

HEAVY, MICROCRYSTALLINE POWDER

WHITE POWDER

Solubility · 3 items

Insoluble

PRACTICALLY INSOL IN WATER, ALC; SOL IN DILUTE HYDROCHLORIC ACID & NITRIC ACID

PRACTICALLY INSOL IN ORGANIC SOLVENTS

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Boiling Point · 2 items

Decomposes at 260

BOILING POINT: 260 °C -HNO3 /BIONO3.H2O/

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

This chemical does not meet GHS hazard criteria for 58.1% (115 of 198) of all reports.

Danger

H272 (24.2%): May intensify fire; oxidizer [Danger Oxidizing liquids; Oxidizing solids]

P210, P220, P260, P261, P264, P264+P265, P270, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 198 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

Hazard information

Regulatory Information · 4 items

Chemical: Bismuth hydroxide nitrate oxide, (Bi5(OH)9(NO3)4O)

Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: Bismuth hydroxide nitrate oxide (EC: 215-136-8)

Bismuth hydroxide nitrate oxide: HSNO Approval: HSR001433 Approved with controls

Fire PotentialHAZARD: OXIDIZING MATERIAL; FIRE RISK NEAR ORGANIC MATERIALS.
Hazards SummaryAn irritant; Oxidizing agent--keep away from combustible materials; [MSDSonline] See Bismuth. See NITRATES and NITRITES.
Hazard Classes and Categories · 2 items

Ox. Sol. 2 (24.2%)

Specific target organ toxicity - Single exposure - Category 2 (central nervous system, blood)

Chemistry & industry

Pharmacology

ATC Code · 2 items

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingUpon accumulation in the kidneys, bismuth may bind to a bismuth-metal binding protein in the kidney.
Pharmacodynamics · 1 item

Bismuth subnitrate acts as an antacid that exert protective effects on the gastric mucosa. In a double-blind endoscopically controlled study, bismuth substrate was demonstrated to be effective for symptomatic relief in duodenal ulcers. In the alcohol model of mucosal injury in the rat, bismuth substrate was shown to be cytoprotective. In a randomized clinical study consisting of patients with _H. pylori_-associated duodenal ulcer, adjunctive use of colloidal bismuth subnitrate in a short treatment regimen with omeprazole and clarithromycin resulted in improved eradication rate of _H. pylori_.

Mechanism of Action · 1 item

Based on the findings of a clinical investigation in patients with duodenal ulcer disease and healthy volunteers receiving oral bismuth subnitrate tablets, the protective effects of bismuth subnitrate may be secondary to endogenous mucosal prostaglandin (PGE2) production, which is one of the deficient factors observed in peptic ulcer disease. Antacid neutralizing activity of bismuth subnitrate was demonstrated to have a significant postprandial effect on gastric pH.

Biological Half-LifeThe distribution half-life of bismuth is approximately 1 to 4 hours, and the elimination half-life is 5 to 11 days.
Metabolism/MetabolitesNo pharmacokinetic data available.
FDA Pharmacological Classification · 4 items

BISMUTHUM SUBNITRICUM

Bismuth [CS]; Bismuth [EPC]

BISMUTH SUBNITRATE

Bismuth [CS]; Bismuth [EPC]

MeSH Pharmacological Classification

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Decomposition
Decomposes to Bi2O3 and nitrogen oxides when heated to red heat.
Melting Point · 2 items

Decomposes at 260

260 °C DECOMP

Physicochemical properties

Melting point
260 °C · 260°C
bulk density
600 kg/m3 · 600kg/m3
Density
4.928 · 4.928
vapor pressure
0 Pa · 0Pa at 20℃
storage temp.
5 °C · Store at +5°C to +30°C.
solubility
Practically insoluble in water and in ethanol (96 per cent). It dissolves in mineral acids with decomposition.
form
Powder/Solid
color
White
PH
3.2 · 3.2 (50g/l, H2O, 20℃)(slurry)
Water Solubility
3 · Practically insoluble in water and alcohol. Soluble in dilute HNO{3} and HCl
Sensitive
Hygroscopic
Merck
14 · 14,1284
Stability
Stability Strong oxidizer - contact with combustible material may lead to fire. Incompatible with reducing agents, organic materials.
Major Application
pharmaceutical (small molecule)
Cosmetics Ingredients Functions
OPACIFYINGABSORBENT
InChI
1S/5Bi.4NO3.9H2O.O/c;;;;;4*2-1(3)4;;;;;;;;;;/h;;;;;;;;;9*1H2;/q+1;4*+3;4*-1;;;;;;;;;;/p-9
InChIKey
OAVDTZZNYFIIGB-UHFFFAOYSA-E
SMILES
O[Bi]=O.O[Bi](O)O[N+]([O-])=O.O[Bi](O)O[N+]([O-])=O.O[Bi](O)O[N+]([O-])=O.O[Bi](O)O[N+]([O-])=O
CAS DataBase Reference
1304 · 1304-85-4(CAS DataBase Reference)
FDA 21 CFR
310.545 · 310.545; 331.11
EWG's Food Scores
1 · 1-4
FDA UNII
19 J064BA5 · H19J064BA5
ATC code
2 BX12 · A02BX12
EPA Substance Registry System
Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) (1304-85-4)
UNSPSC Code
12352302 · 12352302
NACRES
55 · NA.55
Symbol(GHS)
3 · GHS03,GHS07
Signal word
Danger
Hazard statements
272 · H272-H315-H319-H335
Precautionary statements
210 a-P220-P221-P305+P351+P338-P405-P501a · P210a-P220-P221-P305+P351+P338-P405-P501a
PPE
3 · Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
O,Xi
Risk Statements
8 · 8-36/37/38
Safety Statements
17 · 17-26-36/37/39-36
RIDADR
1477 · UN 1477 5.1/PG 2
WGK Germany
3 · 3
RTECS
2977000 · EB2977000
F
8 · 8
TSCA
TSCA listed
HS Code
2834299090 · 2834299090
HazardClass
5.1 · 5.1
PackingGroup
II
Storage Class
13 · 13 - Non Combustible Solids
Hazardous Substances Data
1304 · 1304-85-4(Hazardous Substances Data)
Toxicity
1 gm/kg · infant,LDLo,oral,1gm/kg (1000mg/kg),"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 134, 1969.
REACH Registrations
Active
Hazardous Reactivities and Incompatibilities
Incompatible with alkaline bicarbonates, soluble iodides, gallic acid, calomel, salicylic acid, tannin, and sulfur.

Safety & protection

Storage Conditions · 2 items

...MATERIALS WHICH ARE TOXIC AS STORED OR WHICH CAN DECOMPOSE INTO TOXIC COMPONENTS...SHOULD BE STORED IN A COOL, WELL-VENTILATED PLACE, OUT OF THE DIRECT RAYS OF THE SUN, AWAY FROM...FIRE HAZARD...PERIODICALLY INSPECTED & MONITORED. /NITRATES/

Keep well closed and protect from light.

Toxicology

InteractionsThe gastrointestinal absorption of bismuth subnitrate has been reported ... to be increased by concomitant administration of sulfhydryl compounds.
Adverse EffectsMethemoglobinemia - The presence of increased methemoglobin in the blood; the compound is classified as secondary toxic effect
Human Toxicity Excerpts · 4 items

ESPECIALLY IN INFANTS, THE SUBNITRATE MAY BE REDUCED BY BACTERIA WITHIN THE BOWEL, TO YIELD NITRITE, WHICH CAUSES METHEMOGLOBINEMIA AFTER ABSORPTION.

A PT POISONED BY TAKING 8 G OF BISMUTH SUBNITRATE TEMPORARILY HAD FOGGY VISION ON 2ND DAY OF POISONING.

CLIN SYMPTOMS AND LAB EXAM FINDINGS OF CASE OF POISONING (CENTRAL NERVOUS SYSTEM SYNDROME) AFTER A LONG-TERM INTAKE OF BI SUBNITRICUM (3 G/DAY, 2-3 WK) ARE REPORTED. DISCONTINUATION OF DRUG COMPLETELY IMPROVED CLIN SYMPTOMS.

ORAL ADMIN...PRODUCES POISONING THROUGH THE FORMATION OF NITRITES.

Non-Human Toxicity Excerpts · 5 items

FOLLOWING SC INJECTIONS (5 G OF BISMUTH SUBNITRATE EACH DAY FOR 3 DAYS), DEGENERATIVE CHANGES & INTRANUCLEAR & INTRACYTOPLASMIC INCLUSIONS APPEARED IN RENAL PROXIMAL TUBULES OF RABBITS.

.../TREATMENT/ OF DOGS BY DAILY SC INJECTION OF BISMUTH SUBNITRATE...INDUCED IRRITATION OF EYES & LACRIMATION & RESULTED IN DEVELOPMENT OF WHITE OPACITIES IN UPPER 2/3 OF CORNEAS.

MICRONIZED HEAVY BISMUTH SUBNITRATE FED TO 99 FEMALE SPF RATS 60-70 DAYS (BI 5 G/KG/DAY), WITH 69 RATS AS CONTROLS. TEST ANIMALS BODY WT MUCH LOWER. DIFFERENCES IN LIVER & KIDNEY WT OF 2 GROUPS. TEST ANIMALS BI BLOOD & CEREBRAL LEVELS 200 & 5 TIMES HIGHER, RESPECTIVELY.

IN MICE, BI SUBNITRATE (0.4 ML/20 G OF STD SOLN, IV) WAS LETHAL WHEN DISSOLVED IN WATER, BUT NOT WHEN IN NACL SOLN. MICE ADMIN 500 MG/KG ORALLY HAD SOFTER STOOLS, AS COMPARED TO CONTROLS, AND FACIAL EDEMA.

For more Non-Human Toxicity Excerpts (Complete) data for BISMUTH SUBNITRATE (6 total), please visit the HSDB record page.

Safety data

F
8
PPE
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
tsca
TSCA listed
rtecs
EB2977000
ridadr
UN 1477 5.1/PG 2
hs_code
2834299090
Toxicity
infant,LDLo,oral,1gm/kg (1000mg/kg),"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 134, 1969.
risk_code
8-36/37/38
Signal word
Danger
Symbol(GHS)
GHS03,GHS07
hazard_code
O,Xi
safety_code
17-26-36/37/39-36
hazard_class
5.1
Storage Class
13 - Non Combustible Solids
packing_group
II
Hazard statements
H272-H315-H319-H335
REACH Registrations
Active
Precautionary statements
P210a-P220-P221-P305+P351+P338-P405-P501a
Hazardous Substances Data
1304-85-4(Hazardous Substances Data)
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
Absorption, Distribution and Excretion · 5 items

Bismuth subnitrate may undergo minimal gastrointestinal absorption which may be potentiated with concomitant administration of sulfhydryl compounds when dissolved in citrate buffer solution. Approximately 0.2% of orally administered bismuth is absorbed systematically from the gastrointestinal tract with the peak plasma concentration typically occurring within 1 hour.

Bismuth may undergo both urinary and faecal excretion, however the exact proportion contributed by each route is still unknown.

Bismuth has been shown to accumulate preferentially in the kidneys.

No pharmacokinetic data available.

WITH DAILY ORAL ADMIN OF 0.5 G/KG BISMUTH SUBNITRATE, BLOOD BI LEVELS WERE GREATER WITH HEAVY MICRONIZED (665 UG/L) THAN WITH ORDINARY HEAVY BI SUBNITRATE (85 UG/L). KIDNEY BI LEVELS WERE 17 TIMES GREATER THAN LIVER LEVELS WHILE LITTLE BI PASSED INTO THE BRAIN.

Uses & manufacturing

Uses · 5 items

Used to make enamel fluxes, cosmetics, antacids, and antiulceratives; [Merck Index] Used as an astringent, adsorbent, and protective; in topical lotions and ointments; [HSDB]

Enameling [Category: Hobbies]

IN PREPN OF MILK OF BISMUTH, AS ASTRINGENT, ADSORBENT, & PROTECTANT

COATING AGENT IN PREPARATIONS FOR GASTRITIS; IN BLEACHING CREAMS

Medication

U.S. Imports(1972) 2.83X10+6 GRAMS
U.S. Production2023: 1,000,000 - <8,500,000 lb
Industry UsesCatalyst
Methods of ManufacturingPREPARED BY PARTIAL HYDROLYSIS OF BI(NO3)3
Formulations/Preparations · 2 items

GRADES: TECHNICAL; CP; NF.

VET: /9% BISMUTH SUBNITRATE FORMULATION/... FOR TREATMENT OF SKIN CONDITIONS SUCH AS MINOR WOUNDS, ABRASIONS, ECZEMAS & INFLAMMATION OF EXTERNAL EAR CANAL.

Use ClassificationCosmetics -> Opacifying; Absorbent
General Manufacturing Information · 4 items

Paint and Coating Manufacturing

Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O): ACTIVE

INCOMPATIBILITIES: ALKALINE BICARBONATES, SOLUBLE IODIDES, GALLIC ACID, CALOMEL, SALICYLIC ACID, TANNIN, SULFUR.

(VET): HAS BEEN USED EXTERNALLY IN DUSTING POWDERS FOR INDOLENT, MOIST OR SUPPURATING LESIONS, & AS AN X-RAY CONTRAST MEDIUM.

Applications · 4 items

DescriptionBismuth subnitrate, also referred to as bismuth oxynitrate or bismuthyl nitrate, is a highly water-soluble crystalline compound that has been used as a treatment for duodenal ulcers and anti-diarrheic agent. The use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA. Bismuth Subnitrate is a basic salt that contains the equivalent of not less than 79.0 percent of bismuth trioxide (Bi2O3),calculated on the dried basis.It is both odorless and tasteless, and is used in bleaching and freckle creams, and hair dyes. Bismuth subnitrate has been used to induce metallothionein in heart tissue and kidneys and to attenuate the toxicity of Adriamycin and cisplatin compounds, respectively.

Usesmanufacture of bismuth fluxes for enamels; in cosmetics.

UsesBismuth subnitrate (BiNO3) is used in the cosmetics industry and to make ceramic and enamel glazes.

UsesIt is used pharmaceutically in wound dressing, ointment component and as an antiacid. In cosmetics it is used as a cosmetic white pigment. Used in Ceramic glazes and enamel fluxes.